Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001989258 | SCV002278864 | benign | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001989258 | SCV004236027 | uncertain significance | not provided | 2023-05-24 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003913477 | SCV004729999 | uncertain significance | PIEZO1-related disorder | 2024-01-23 | no assertion criteria provided | clinical testing | The PIEZO1 c.4623C>A variant is predicted to result in the amino acid substitution p.Asp1541Glu. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.024% of alleles in individuals of African descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |